Evosep ApS: Financial statements 2017
CVR: 37510068
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Evosep ApS (CVR 37510068) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -2,722,228 and a net result of DKK -8,613,473 compared with DKK -4,195,093 the year before. Equity in the 2017 report amounted to DKK 7,228,553. The solvency ratio was 75%.
- Gross Profit
- DKK -2,722,228
- Profit/Loss
- DKK -8,613,473
- Equity
- DKK 7,228,553
- Total Assets
- DKK 9,631,829
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -2.7 mio. | -8.6 mio. | 7.2 mio. | - |
| 2016 | - | -1.2 mio. | -4.2 mio. | 7.9 mio. | - |
Keep an eye on Evosep ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Evosep ApS has published its interim report for the period March 1, 2016 – December 31, 2016.
About Evosep ApS
Evosep ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Omics Ready Biosystems ApS. The management consists of Morten Bern. The company is owned by Paradigm BidCo ApS. The company has 16 employees (2018). In 2025, the company reported a gross profit of DKK 72,369,000 and a net result of DKK -221,637,000 compared with DKK -2,613,000 the year before. Equity in the 2025 report amounted to DKK 154,548,000.